Is W1RB34 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of W1RB34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: W1RB34 (R$35.16) is trading below our estimate of fair value (R$37.47)
Significantly Below Fair Value: W1RB34 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for W1RB34?
Key metric: As W1RB34 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for W1RB34. This is calculated by dividing W1RB34's market cap by their current
earnings.
What is W1RB34's PE Ratio?
PE Ratio
14.7x
Earnings
US$1.58b
Market Cap
US$23.15b
W1RB34 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: W1RB34 is expensive based on its Price-To-Earnings Ratio (14.7x) compared to the Global Insurance industry average (11.4x).
Price to Earnings Ratio vs Fair Ratio
What is W1RB34's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
W1RB34 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
14.7x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate W1RB34's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.